Coliseum Capital Adds To Its Stake In BioScrip Inc (BIOS)

Page 2 of 10

Page 2 of 10 – SEC Filing

CUSIP No. 09069N108 (Common Stock)

  1.

Names of
Reporting Persons.

Coliseum Capital Management, LLC

  2.

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ¨        (b)  x

  3.

SEC Use Only

  4.

Source of Funds (See Instructions)

AF

  5.

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)

¨

  6.

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7.

Sole Voting Power

0

  8.

Shared Voting Power

23,182,758 (1)

  9.

Sole Dispositive Power

0

10.

Shared Dispositive Power

23,182,758 (1)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

23,182,758 (1)

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)

¨

13.

Percent of Class Represented by Amount
in Row (11)

17.6% (1)

14.

Type of Reporting Person (See
Instructions)

IA

(1) Includes (a) 5,622,410 shares of common stock, $0.0001 par value per share (the Common Shares), (b) 241,749 Common Shares that could be obtained upon conversion of 10,823 shares of Series A
Convertible Preferred Stock, par value $0.0001 per share at a conversion price of $5.17 per share (the Series A Preferred Shares), (c) 13,718,600 Common Shares that could be obtained upon conversion of 614,177 shares of Series C
Convertible Preferred Stock, par value $0.0001 per share at a conversion price of $5.17 per share (the Series C Preferred Shares), (d) 1,800,000 Common Shares that could be obtained upon conversion of 1,800,000 Class A warrants
to purchase Common Shares at a price of $5.17 per share (the Class A Warrants), and (e) 1,800,000 Common Shares that could be obtained upon conversion of 1,800,000 Class B warrants to purchase Common Shares at a price of $6.45 per
share (the Class B Warrants and, together with the Class A Warrants, the Warrants).

Page 2 of 9

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 2 of 10